Andros
PrivateLast Round
Series B
Extension
Jul 14, 2021
Est. Valuation
$333,000
Total Funding Raised
$38.44M
Company Overview
Andros operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series B Extension round in July 2021.
Andros is a healthcare technology company that provides a platform for provider network management, including recruitment, contracting, credentialing, and data management services.
Sector
Healthcare & Life Sciences
Verticals
Compliance & Risk, Workflow Automation, Vertical SaaS, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Andros Comparables
Compare Andros with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Verifiable | 87% | |
| CertifyOS | 85% | |
| Veda AI | 82% |
For institutional investors. Book with your work email.
Andros Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jul 14, 2021 | ||||
| Series B Extension | Jan 28, 2020 | ||||
| Series B | Jun 12, 2019 | ||||
| Seed | Jul 1, 2015 | ||||
| Accelerator | Jul 12, 2013 | ||||
Accelerator | Apr 5, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Andros Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Questa Capital | Series B |
| Bowery Capital | Seed |
| Windham Capital Partners | Series B, Series A |
| Primary Ventures | Series B |
| Blueprint Health | Accelerator |
| Primary Venture Partners | Seed, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 17, 2025
Added Talkspace, a telehealth and mental health provider, as a customer.
- Jul 1, 2015
$2M round led by Bowery Capital
For institutional investors. Book with your work email.
Andros Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Andros's valuation, stock price, and market status.
Is Andros a public or private company?
Andros is a private company.
What is the current stock price of Andros?
Andros is a private company, so its shares have no public market price. Caplight tracks Andros's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Andros worth (valuation)?
Andros's valuation is estimated at $333.0K based on funding round data.
Can I buy Andros stock?
Andros shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Andros's last funding round?
Andros's most recent funding round was Series B Extension on July 14, 2021.
Who are the main investors in Andros?
Key investors in Andros include Questa Capital, Bowery Capital, Windham Capital Partners, Blueprint Health.
Will Andros IPO soon?
No public IPO plans have been announced for Andros.
How can I track Andros secondary market activity?
Caplight tracks bids, offers, and trades in Andros's shares on secondary markets.